Globus Medical Announces over 115,000 Robotic Procedures with the Excelsius Platform – Q3 Sets new Records!

Globus Medical (GMED) specializes in treatments for musculoskeletal disorders and broadened its portfolio by acquiring NuVasive in 2023. The US spinal business accelerated sequential growth from 5.7% to 9.6% and achieved 32 weeks of consecutive gains. The trauma portfolio was also expanded, now covering 80% of competitors' portfolios and allowing for more contract wins as a full-service trauma supplier. The segment recently achieved its highest revenue in company history with nearly 18% growth. With the Excelsius platform, approved since 2017,...